Psychiatria pre prax 2/2016
Aripiprazole in the treatment of schizophrenia – its use in clinical practice
There are available many types of antipsychotics in recent days. Aripiprazole is a partial agonist of D2 and 5-HT1A and antagonist of 5-HT2A receptors. It belongs among antipsychotics with low occurrence of averse events, especially metabolic like increase body weight, prolactine level. We demonstrate on 3 case reports of schizophenic patients when is possible to use aripiprazole in their treatment.
Keywords: aripiprazole, schizophrenia, efficacy, tollerability, augmentation, atypic antipsychotics
